GPT and hepatocellular carcinoma: Patients with late HCC recurrence had higher alanine aminotransferase (ALT; mean, 59.4 vs. 33.7 IU/mL; P = 0.004) and higher HBV DNA level (mean, 2.2 vs. 1.5 log10 IU/mL; P = 0.002) levels than those without recurrence (Table 3).